FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Björn Andréasson

Research Profile

Disorders

Chemicals & Drugs

Geographic Areas

Sweden

Procedures

Anatomy

Hematopoietic Stem Cells

Concepts & Ideas

Platelet Count

Co-author Network

Publications

TOP 3
Peter Johansson; Ruben Mesa; Jan Samuelsson; Robyn Scherber; Johanna Abelsson; Gunnar Birgegård; Björn Andréasson
Association between quality of life and clinical parameters in patients with myeloproliferative neoplasms.
J Abelsson; Björn Andréasson; Gunnar Birgegård; L Brinch; M Brune; Peter Johansson; M Kauppila; Stig Lenhoff; M Liljeholm; C Malm; Mats Merup; K Remes; L Vindelöv; O WeisBjerrum
The outcome of allo-HSCT for 92 patients with myelofibrosis in the Nordic countries.
Khadija Abdulkarim; Börje Ridell; Peter Johansson; Jack Kutti; Soodabeh Safai-Kutti; Björn Andréasson
The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Björn Andréasson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Peter Johansson; Ruben Mesa; Jan Samuelsson; Robyn Scherber; Johanna Abelsson; Gunnar Birgegård; Björn Andréasson
Association between quality of life and clinical parameters in patients with myeloproliferative neoplasms.
Leukemia & lymphoma 2012;53(3):441-4.
2012: J Abelsson; Björn Andréasson; Gunnar Birgegård; L Brinch; M Brune; Peter Johansson; M Kauppila; Stig Lenhoff; M Liljeholm; C Malm; Mats Merup; K Remes; L Vindelöv; O WeisBjerrum
The outcome of allo-HSCT for 92 patients with myelofibrosis in the Nordic countries.
Bone marrow transplantation 2012;47(3):380-6.
2011: Khadija Abdulkarim; Börje Ridell; Peter Johansson; Jack Kutti; Soodabeh Safai-Kutti; Björn Andréasson
The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera.
European journal of haematology 2011;86(2):148-55.
2009: Khadija Abdulkarim; François Girodon; Peter Johansson; Marc Maynadié; Jack Kutti; Paule-Marie Carli; Emeline Bovet; Björn Andréasson
AML transformation in 56 patients with Ph- MPD in two well defined populations.
European journal of haematology 2009;82(2):106-11.
2004: Peter Johansson; Anne Ricksten; Carina Wasslavik; Berit Johansson; Björn Andréasson
The effects of hydroxyurea on PRV-1 expression in patients with essential thrombocythemia and polycythemia vera.
Haematologica 2004;89(10):1264-6.
2004: Peter Johansson; Jack Kutti; Björn Andréasson; Soodabeh Safai-Kutti; Lars Vilén; Hans Wedel; Börje Ridell
Trends in the incidence of chronic Philadelphia chromosome negative (Ph-) myeloproliferative disorders in the city of Göteborg, Sweden, during 1983-99.
Journal of internal medicine 2004;256(2):161-5.
2004: Peter Johansson; G Brudin; B Nilsson; Björn Andréasson
Oxygen affinity is decreased in patients with polycythaemia vera and essential thrombocythaemia.
Scandinavian journal of clinical and laboratory investigation 2004;64(1):71-5.
2003: Peter Johansson; Anne Ricksten; Lovisa Wennström; Lars Palmqvist; Jack Kutti; Björn Andréasson
Increased risk for vascular complications in PRV-1 positive patients with essential thrombocythaemia.
British journal of haematology 2003;123(3):513-6.
2003: Peter Johansson; Björn Andréasson; Soodabeh Safai-Kutti; Lovisa Wennström; Lars Palmqvist; Anne Ricksten; Göran Lindstedt; Jack Kutti
The presence of a significant association between elevated PRV-1 mRNA expression and low plasma erythropoietin concentration in essential thrombocythaemia.
European journal of haematology 2003;70(6):358-62.
2003: Björn Andréasson; Claire Harrison; Göran Lindstedt; David C Linch; Jack Kutti
Monoclonal myelopoiesis and subnormal erythropoietin concentration are independent risk factors for thromboembolic complications in essential thrombocythemia.
Blood 2003;101(2):783.
2002: Björn Andréasson; Birgitta Swolin; Jack Kutti
Patients with idiopathic myelofibrosis show increased CD34+ cell concentrations in peripheral blood compared to patients with polycythaemia vera and essential thrombocythaemia.
European journal of haematology 2002;68(4):189-93.
2002: Peter Johansson; Björn Andréasson; Soodabeh Safai-Kutti; C Rhedin; Lars Vilén; J Väärt; Jack Kutti
On the diagnosis of polycythaemia vera as assessed in the health and medical care in the Västra Götaland region, Sweden.
Journal of internal medicine 2002;251(4):348-54.
2001: Björn Andréasson; Göran Lindstedt; Dick Stockelberg; Hans Wadenvik; Jack Kutti
The relation between plasma thrombopoietin and erythropoietin concentrations in polycythaemia vera and essential thrombocythaemia.
Leukemia & lymphoma 2001;41(5-6):579-84.
2000: Björn Andréasson; Göran Lindstedt; Jack Kutti
Plasma erythropoietin in essential thrombocythaemia: at diagnosis and in response to myelosuppressive treatment.
Leukemia & lymphoma 2000;38(1-2):113-20.
2000: Björn Andréasson; Birgitta Swolin; Jack Kutti
Hydroxyurea treatment reduces haematopoietic progenitor growth and CD34 positive cells in polycythaemia vera and essential thrombocythaemia.
European journal of haematology 2000;64(3):188-93.
2000: Björn Andréasson; Jan Carneskog; Göran Lindstedt; P A Lundberg; Birgitta Swolin; Hans Wadenvik; Jack Kutti
Plasma erythropoietin concentrations in polycythaemia vera with special reference to myelosuppressive therapy.
Leukemia & lymphoma 2000;37(1-2):189-95.
1999: Björn Andréasson; E Wahlström; S Jacobsson; Magnus Björkholm; Jan Samuelsson; Gunnar Birgegård; Hans Wadenvik; Jack Kutti
The measurement of venous haematocrit in patients with polycythaemia vera.
Journal of internal medicine 1999;246(3):293-7.
1997: Björn Andréasson; Birgitta Swolin; Jack Kutti
Increase of CD34 positive cells in polycythaemia vera.
European journal of haematology 1997;59(3):171-6.